(S)-2-(3-dodecyl-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide hydrochloride

ID: ALA3627778

Chembl Id: CHEMBL3627778

PubChem CID: 122192899

Max Phase: Preclinical

Molecular Formula: C19H36ClN5O

Molecular Weight: 349.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCc1noc([C@@H]2CCCN2C(=N)N)n1.Cl

Standard InChI:  InChI=1S/C19H35N5O.ClH/c1-2-3-4-5-6-7-8-9-10-11-14-17-22-18(25-23-17)16-13-12-15-24(16)19(20)21;/h16H,2-15H2,1H3,(H3,20,21);1H/t16-;/m0./s1

Standard InChI Key:  FIGDFYXBTDNLQV-NTISSMGPSA-N

Associated Targets(Human)

SPHK1 Tchem Sphingosine kinase 1 (1990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sphk2 Sphingosine kinase 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 349.52Molecular Weight (Monoisotopic): 349.2842AlogP: 4.56#Rotatable Bonds: 12
Polar Surface Area: 92.03Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.22CX LogP: 5.38CX LogD: 2.91
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.33Np Likeness Score: -0.75

References

1. Congdon MD, Childress ES, Patwardhan NN, Gumkowski J, Morris EA, Kharel Y, Lynch KR, Santos WL..  (2015)  Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.,  25  (21): [PMID:25862200] [10.1016/j.bmcl.2015.03.041]

Source